Rallybio Corporation

NASDAQ: RLYB · Real-Time Price · USD
0.59
0.04 (8.06%)
At close: Aug 15, 2025, 3:49 PM

Rallybio Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
761K 848K 636K 826K 527K 228K 228K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
69K 103K 138K 105K 142K 146K 150K 114K 119K 125K 128K 163K 147K 128K 109K 74K 48K 23K
Gross Profit
519K 784K 537K 721K 385K 82K 78K -114K -119K -125K -128K -163K -147K -128K -109K -74K -48K -23K
Operating Income
-43.4M -50.38M -60.5M -70M -77.3M -80.34M -78.93M -74.91M -74.41M -71.94M -67.88M -63.11M -54.23M -47.14M -45.65M -43.42M -40.15M -34.28M
Interest Income
2.96M 3.58M 4.22M 4.85M 5.41M 5.88M 6.15M 5.77M 4.75M 3.41M 1.96M 904K 391K 134K 54K 69K 99K 133K
Pretax Income
-41.65M -47.7M -56.6M -65.19M -72.1M -74.76M -73.17M -69.53M -69.39M -68.23M -65.58M -61.78M -53.41M -46.82M -45.51M -43.32M -40.09M -33.98M
Net Income
-41.65M -48.19M -57.77M -66.97M -73.88M -76.28M -72.91M -68.87M -68.3M -67.25M -65.99M -62.2M -54.59M -48.14M -47.01M -45.12M -42.08M -35.84M
Selling & General & Admin
16.74M 16.93M 19.63M 20.55M 22.5M 25.07M 25.39M 26.5M 27.17M 27.7M 27.2M 27.12M 25.39M 21.62M 18.74M 15.11M 11.67M 9.53M
Research & Development
27.39M 34.23M 41.41M 49.94M 54.99M 55.21M 53.51M 48.41M 47.23M 44.24M 40.69M 35.99M 28.84M 25.52M 26.91M 28.31M 28.48M 24.75M
Other Expenses
n/a 143K 310K 345K 437K 356K 262K 227K 233K 271K 311K 420K 322K 222K 133K 92K 144K 144K
Operating Expenses
44.13M 51.16M 61.03M 70.49M 77.49M 80.27M 78.9M 74.91M 74.41M 71.94M 67.88M 63.11M 54.23M 47.14M 45.65M 43.42M 40.15M 34.28M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a 525K 525K 622K 622K 97K 97K 10K 22K 35K 47K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
34.03M 51.37M 61.27M 70.6M 77.6M 80.34M 78.93M 74.91M 74.41M 71.94M 67.88M 63.11M 54.23M 47.14M 45.65M 43.42M 40.15M 34.28M
Income Tax Expense
-430K 57K 742K 1.17M 1.14M 865K -915K -701K -1.1M -1.25M -152K -264K 607K 539K 539K 438K 1K 1K
Shares Outstanding (Basic)
44.84M 44.77M 44.66M 44.59M 44.13M 40.77M 40.64M 40.53M 40.36M 40.25M 35.52M 30.78M 30.59M 30.32M 29.79M 27.53M 30.75M 22.24M
Shares Outstanding (Diluted)
44.84M 44.77M 44.66M 44.59M 44.13M 40.77M 40.64M 40.53M 40.36M 40.25M 35.52M 30.78M 30.59M 30.32M 29.79M 27.53M 30.75M 22.24M
EPS (Basic)
-0.94 -1.09 -1.35 -1.6 -1.79 -1.88 -1.8 -1.76 -1.89 -2 -2.08 -2.04 -1.83 -1.62 -1.75 -1.8 -1.75 -1.61
EPS (Diluted)
-0.94 -1.09 -1.35 -1.6 -1.79 -1.88 -1.8 -1.76 -1.89 -2 -2.08 -2.04 -1.83 -1.62 -1.75 -1.8 -1.75 -1.61
EBITDA
-43.31M -50.26M -60.37M -69.86M -77.16M -80.2M -78.78M -73.66M -72.53M -70.05M -65.78M -61.99M -53.63M -46.7M -45.39M -43.2M -39.97M -33.87M
EBIT
-33.34M -49.09M -59.21M -68.71M -76.01M -80.34M -78.93M -74.91M -73.78M -70.95M -66.68M -61.78M -53.41M -46.82M -45.5M -43.31M -40.06M -33.95M
Depreciation & Amortization
90K 124K 131K 137K 142K 146K 150K 153K 158K 164K 167K 163K 147K 128K 109K 94K 83K 72K